Fundz

Gel Medix reported raising $1.89 Million in an initial SEC Form D filing, from an offering of $3.5 Million

PRIVATEMar 26, 2024$1.9M of $3.5M raised

Amount Raised

$1.89 Million

$1.89 Million sold, per SEC Form D (first sale Mar 11, 2024)

Round Type

Seed

CambridgeBiotechnology

Who else raised in Biotechnology around the same time

Companies in the same sectors as GelMEDIX that raised within 45 days of this round, from Fundz verified event records.

  • RevOpsis Therapeutics raised $17M (Seed) on April 25, 2024.
  • PinkDx raised $40M (Series A) on April 25, 2024.
  • Owlstone Medical raised $6.5M (Grant) on April 25, 2024.
  • Glen Clova Scientific raised $5M (Seed) on April 25, 2024.
  • Xaira Therapeutics raised $1B (Funding Round) on April 25, 2024.
  • Sequella raised $20M on April 25, 2024.

Who to call at GelMEDIX, and when

A new round usually means GelMEDIX is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day GelMEDIX raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at GelMEDIX, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at GelMEDIX. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

GelMEDIX

Location

238 Main Street, Fifth Floor

Cambridge, Massachusetts, United States

About

GelMEDIX Inc. is an early-stage biotechnology company leveraging its hydrogel platform to develop ocular and regenerative therapies that can restore vision.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment GelMEDIX raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsNasim A., Scientific Co-Founder hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for GelMEDIX's next move

See what Strategic adds

GelMEDIX raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.